Haoxiangni Health FoodLtd Second Quarter 2024 Earnings: CN¥0.14 loss per share (vs CN¥0.064 loss in 2Q 2023)
Haoxiangni Health FoodLtd (SZSE:002582) Second Quarter 2024 Results
Key Financial Results
- Revenue: CN¥322.6m (up 13% from 2Q 2023).
- Net loss: CN¥48.8m (loss widened by 60% from 2Q 2023).
- CN¥0.14 loss per share (further deteriorated from CN¥0.064 loss in 2Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Haoxiangni Health FoodLtd shares are up 2.1% from a week ago.
Risk Analysis
What about risks? Every company has them, and we've spotted 2 warning signs for Haoxiangni Health FoodLtd you should know about.
Valuation is complex, but we're here to simplify it.
Discover if Haoxiangni Health FoodLtd might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About SZSE:002582
Haoxiangni Health FoodLtd
Engages in the research, development, procurement, production, and sale of healthy foods in China.
Excellent balance sheet and good value.
